Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Monthly Archives: February 2016

Interview: For the National Institutes of Health, An Infusion of Cash for Biomedical Research

Francis Collins NIH DirectorBethesda, MD, February 16, 2016 ― Thomas M. Burton reports in The Wall Street Journal that the National Institutes of Health (NIH) can see the light at the end of a decadelong financial tunnel—a $2 billion boost to its current budget, delivered by Congress in December.

Francis Collins, director of the nation’s premier agency for biomedical research, calls it “the most encouraging budget outcome in 12 years.” For 2017, the Obama administration is asking for $33.1 billion in spending power, up from $32.3 billion this year.

The rosier outlook for agency follows more than a decade of basically flat budgets.  Increases in 2009 and 2010, in connection with the federal economic-stimulus package, were the exception. Continue reading

BioNJ Releases ‘Fueling Entrepreneurship: Advancing Innovation and the Life Sciences Ecosystem’

BioNJ White Paper 20160216Newark, NJ, February 16, 2016 BioNJ, the trade association for New Jersey’s life sciences industry, has released Fueling Entrepreneurship: Advancing Innovation and the Life Sciences Ecosystem, a white paper highlighting key findings from a state-wide survey of entrepreneurs intended to identify opportunities and strategies to support the important role of life sciences entrepreneurship.

New Jersey and the surrounding region represents a hotbed of life sciences activity, boasting the full complement of large and small biopharmaceutical companies, universities and research institutions, service providers and talent working together to make meaningful advances in healthcare.

Entrepreneurship is a critical component to ensuring the long-term growth and success of this region and specifically BioNovation, New Jersey’s life sciences innovation cluster. Continue reading

Bayer Brings Science Learning to Schools Through Making Science Make Sense Program

Bayer logoWhippany, NJ, February 16, 2016 ― As a science and innovation company, Bayer has a strong stake in helping to improve science education and to ensure that all individuals are scientifically literate.

The pharmaceutical firm demonstrates this commitment with its national, presidential award-winning Making Science Make Sense (MSMS) program, a company-wide initiative which advances science literacy across the United States through hands-on, inquiry-based science learning, employee volunteerism and public education.

MSMS was formalized in 1995; however, the spirit of the program dates back to nearly 50 years ago, when Bayer volunteers began helping teachers teach and students learn science the way scientists do — by doing it.   Continue reading

Rowan University Pursues Atlantic City Medical School Campus

Glassboro, NJ, February 16, 2016 ― The Philadelphia Inquirer reports that Rowan University is preparing to take the first steps toward creating a medical school campus in Atlantic City, extending the footprint of its growing medical programs and potentially tapping a new student base there.

Rowan trustees are set to vote Wednesday on a feasibility study to explore an Atlantic City partnership between the Rowan University School of Osteopathic Medicine and AtlantiCare.

Trustees will vote on awarding a contract to the Pittsburgh-based consulting firm Tripp Umbach to conduct the study “to understand the impacts associated with a potential four-year branch campus of a medical school,” according to the agenda for Wednesday’s board meeting. Continue reading

NJTC Hosts Second Innovation Forecast

Somerset, NJ, February 15, 2016 ― Andrew Sheldon reports in NJBIZ that the New Jersey Tech Council (NJTC) hosted its second Innovation Forecast on February 11 at the Princeton Plasma Physics Laboratory.

The event featured speakers from Samsung, Campbell Soup Company, Google and Janssen Healthcare.

Its keynote speaker was Sanjay Macwan, senior vice president and chief technology officer at NBCUniversal. In his address, told from the perspective of a media company, he urged the audience to consider the trends he was presenting across all industries.

“It’s really important to look beyond your boundaries at other industries,” he said. Continue reading

Rutgers Appoints Reynold Panettieri to Develop Clinical and Translational Science Institute

New Brunswick, NJ, February 14, 2016Reynold Panietteri M.D., a pulmonologist from the University of Pennsylvania School of Medicine, has joined Rutgers Biomedical and Health Sciences (RBHS) to develop the university’s first clinical and translational science institute and serve as its director.  He will also be the vice chancellor for clinical and translational research.

Dr. Panettieri, leaving his current role as the Robert L. Mayock and David A. Cooper Professor of Pulmonology Medicine at UPenn, assumed his position last month.

Brian Strom, chancellor of RBHS, said Rutgers’ commitment to clinical and translational science is vital to its continued evolution into one of the country’s leading academic health centers.  Continue reading

HINJ Updates Portal of Member Companies’ Corporate Social Responsibility and Sustainability Activities

CSR chasing arrowsNew Brunswick, NJ, February 13, 2016 ― The HealthCare Institute of New Jersey (HINJ) has updated its online portal to HINJ member companies’ myriad corporate social responsibility (CSR) activities, including their corporate philanthropy, patient outreach initiatives and sustainability/green practices.

Launched in November 2014 and promoted via Twitter, Facebook and LinkedIn, HINJ’s CSR online portal has become one of the most-visited areas of the association’s website.

The portal — “HINJ Members’ CSR Activities” — is accessible by clicking on the second tab under the HINJ homepage’s Corporate Social Responsibility menu. Continue reading

FDA Designated a Record Number of Orphan Drugs Last Year

STAT PharmalotBoston, MA, February 12, 2016 ― Pharmalot’s Ed Silverman reports on STAT that orphan drugs may target small patient populations, but they are racking up big numbers at the Food and Drug Administration.

Last year, the agency received a record 472 requests from companies to have their medicines designated as orphan drugs.  And the FDA agreed to award 354 designations, which was a 22 percent increase over 2014.

As for approvals, Silverman reported that the agency endorsed 41 orphan medicines, just seven fewer than the previous year, according to the FDA Office of Orphan Products Development. A designation, by the way, means the FDA has decided a drug qualifies for orphan status and takes place before a drug is approved. Continue reading

Rutgers University to Launch Skin Research Laboratory

Rutgers RNew Brunswick, NJ, February 12, 2016 ― A $1 million grant from the MCJ Amelior Foundation in Morristown will be used to recruit an up-and-coming researcher in the field of skin research and set up a laboratory for the scientist within Rutgers Biomedical and Health Sciences‘ newly launched Institute for Infectious and Inflammatory Diseases (i3D).

“There is so much that is still unknown about chronic, inflammatory skin conditions such as acne, as well as how to better repair skin wounds and injuries,” says William C. Gause, director of  i3D. “Most current acne treatments focus largely on eradicating existing acne lesions and preventing new ones. The research initiative that we are set to launch will look at the underlying causes.” Continue reading

Thirty Organizations to Share Data in Fight Against Spread of Zika Virus

Zika mosquitoBoston, MA, February 11, 2016 ― Eric Boodman reports in STAT that the often-hermetic world of scientific research and publishing is making an exception for the Zika virus.

Thirty organizations — including scientific journals, nonprofit groups, and research institutes — announced jointly on February 10 that they would share any data or results that could be helpful in fighting the spread of Zika.

The announcement of the data-sharing initiative could be especially useful to help investigate Zika, experts say, since so little is known about the virus. Public health officials have expressed frustration with limited access to data during previous health emergencies. Continue reading